Connect with us

Hi, what are you looking for?

Jewish Business News


Mylan, Bruised by Failed Perrigo Bid, Set for Face-Off on Assets

Impax, Stada, Taro may be takeover targets for Mylan, Perrigo; Mylan may also look for assets shed in Teva-Allergan deal

(L-R) Robert J Coury,   Mylan and Joseph Papa,   Perrigo

Mylan NV, bruised by its acrimonious and ultimately unsuccessful bid to buy Perrigo Co., is likely to find itself now competing with the drugmaker for other assets.

Both companies may look to buy Impax Laboratories Inc., a generic-drug maker from Hayward, California; Stada Arzneimittel AG, a German maker of off-patent medicines; or Taro Pharmaceutical Industries Ltd. of Israel, said Elizabeth Krutoholow, a Bloomberg Intelligence analyst in New York. All of them have over-the-counter products, making them attractive targets.


Read the full story at Bloomberg, by Makiko Kitamura

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.